ARTICLE | Clinical News
Repatha evolocumab regulatory update
May 11, 2015 7:00 AM UTC
FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) will meet on June 10 to discuss a BLA from Amgen for Repatha evolocumab to treat high cholesterol. The PDUFA date is Aug. 27. Amgen ...